Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond L Comenzo

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2007
Managing systemic light-chain amyloidosisRaymond L Comenzo
Current Treatment Options in Oncology|April 18, 2006
AmyloidosisRaymond L Comenzo
Blood|July 21, 2009
How I treat amyloidosisRaymond L Comenzo
Blood|March 15, 2014
LECT2 makes the amyloid listRaymond L Comenzo
Contributions to Nephrology|November 1, 2006
Current and emerging views and treatments of systemic immunoglobulin light-chain (Al) amyloidosisRaymond L Comenzo
Clinical Lymphoma & Myeloma|January 19, 2007
Systemic immunoglobulin light-chain amyloidosisRaymond L Comenzo
Oncotargets and Therapy|August 1, 2022
Evaluating the Therapeutic Potential of Idecabtagene Vicleucel in the Treatment of Multiple Myeloma: Evidence to DateHashim Mann, Raymond L Comenzo
Bone Marrow Transplantation|August 10, 2018
High-dose melphalan and stem cell transplantation in systemic AL amyloidosis in the era of novel anti-plasma cell therapy: a comprehensive reviewCindy Varga, Raymond L Comenzo
Sub-Cellular Biochemistry|December 11, 2012
The challenge of systemic immunoglobulin light-chain amyloidosis (Al)Giovanni Palladini, Raymond L Comenzo
Current Treatment Options in Oncology|May 31, 2022
Immunotherapy in AL AmyloidosisYifei Zhang, Raymond L Comenzo
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2007
Managing systemic light-chain amyloidosisRaymond L Comenzo
Current Treatment Options in Oncology|April 18, 2006
AmyloidosisRaymond L Comenzo
Blood|July 21, 2009
How I treat amyloidosisRaymond L Comenzo
Blood|March 15, 2014
LECT2 makes the amyloid listRaymond L Comenzo
Contributions to Nephrology|November 1, 2006
Current and emerging views and treatments of systemic immunoglobulin light-chain (Al) amyloidosisRaymond L Comenzo
Clinical Lymphoma & Myeloma|January 19, 2007
Systemic immunoglobulin light-chain amyloidosisRaymond L Comenzo
Oncotargets and Therapy|August 1, 2022
Evaluating the Therapeutic Potential of Idecabtagene Vicleucel in the Treatment of Multiple Myeloma: Evidence to DateHashim Mann, Raymond L Comenzo
Bone Marrow Transplantation|August 10, 2018
High-dose melphalan and stem cell transplantation in systemic AL amyloidosis in the era of novel anti-plasma cell therapy: a comprehensive reviewCindy Varga, Raymond L Comenzo
Sub-Cellular Biochemistry|December 11, 2012
The challenge of systemic immunoglobulin light-chain amyloidosis (Al)Giovanni Palladini, Raymond L Comenzo
Current Treatment Options in Oncology|May 31, 2022
Immunotherapy in AL AmyloidosisYifei Zhang, Raymond L Comenzo
Pageof 9